Inhaled nitric oxide does not affect adenosine 5'-diphosphate-dependent platelet activation in infants with persistent pulmonary hypertension of the newborn

Pediatrics

Volumn 102, Issue 6, 1998, Pages 1390-1393

  Christou, Helen ^a,b   Magnani, Barbarajean ^a,b   Morse, David S ^b   Allred, Elizabeth N ^a,c   Van Marter, Linda J ^a,b   Wessel, David L ^a   Kourembanas, Stella ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Bleeding; Hemostasis; Platelet function

Indexed keywords

ADENOSINE DIPHOSPHATE; NITRIC OXIDE; PADGEM PROTEIN;

ARTICLE; CLINICAL ARTICLE; HUMAN; LUNG BLOOD FLOW; NEWBORN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; THROMBOCYTE ACTIVATION; VASODILATATION;

EID: 0031795936     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.102.6.1390     Document Type: Article

References (25)

1. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 1992;340:819-820
2. Roberts JD, Polaner DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 1992;340: 818-819
3. Christou H, Adatia I, Van Marter LJ, et al. Effect of inhaled nitric oxide on endothelin-1 and cyclic guanosine 5′-monophosphate plasma concentrations in newborn infants with persistent pulmonary hypertension. J Pediatr. 1997;130:603-611
4. Wessel DL, Adatia I, Giglia TM, Thompson JE, Kulik TJ. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation. 1993;88:2128-2138
5. Abman SH, Griebel JL, Parker DK, Schmidt JM, Swanton D, Kinsella JP. Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure. J Pediatr. 1994;124:881-888
6. Samama CM, Diaby M, Fellahi J-L, et al. Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology. 1995;83:56-65
7. Roberts JD Jr, Fineman JR, Morin FC III, et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Eugl J Med. 1997;336:605-610
8. Kinsella JP, Truog WE, Walsh WF, et al. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr. 1997;131:55-62
9. The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med. 1997;336:597-604
10. Wessel DL, Adatia IA, Van Marter LJ, et al. Improved oxygenation in randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics. 1997;100(5). URL: http:// www.pediatrics.org/cgi/content/full/100/5/e7
11. Abman SH, Kinsella JP, Schaffer MS, Wilkening RB. Inhaled nitric oxide in the management of a premature infant with severe respiratory distress and pulmonary hypertension. Pediatrics. 1993;92:606-609
12. Chirkov YY, Naujalis JI, Sage RE, Horowitz JD. Antiplatelet effects of nitroglycerin in healthy subjects and in patients with stable angina pectoris. J Cardiovasc Pharmacol. 1993;21:384-389
13. Doni MG, Alexandre A, Bertoncello S, Deana R. Nitrovasodilators and cGMP inhibit human platelet activation. Cardioscience. 1991;2:161-165
14. Radomski MW, Palmer RM, Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA. 1990;87:5193-5197
15. Radomski MW, Moncada S. The biological and pharmacological role of nitric oxide in platelet function. Adv Exp Med Biol. 1993;:251-264
16. Sherman S, Fox J, Body S, Morse D, Magnani BJ. Inhaled nitric oxide does not inhibit platelets in healthy human volunteers. Anesthesiology. 1996;85:A39. Abstract
17. Albert J, Wallén NH, Bröijersén A, Frostell C, Hjemdahl P. Effects of inhaled nitric oxide compared with aspirin on platelet function in vivo in healthy subjects. Clin Sci. 1996;91:225-231
18. Ault KA, Rinder HM, Mitchell JG, Rinder CS, Lambrew CT, Hillman RS. Correlated measurement of platelet release and aggregation in whole blood. Cytometry. 1989;10:448-455
19. Stenberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DF. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol. 1985;101:880-886
20. Andrew M. The relevance of developmental hemostasis to hemorrhagic disorders of newborns. Sem Perinatol. 1997;21:70-85
21. Setzer ES, Webb IB, Wassenaar JW, Reeder JD, Mehta PS, Eitzman DV. Platelet dysfunction and coagulopathy in intraventricular hemorrhage in the premature infant. J Pediatr. 1982;100:599-605
22. Michelson AD, Benoit SE, Furman MI, et al. Effects of nitric oxide/ EDRF on platelet surface glycoproteins. Am J Physiol. 1996;270: H1640-H1648
23. Gries A, Böttiger BW, Dörsam J, et al. Inhaled nitric oxide inhibits platelet aggregation after pulmonary embolism in pigs. Anesthesiology. 1997;86:387-393
24. Hogman M, Frostell C, Arnberg H, Hedenstierna G. Bleeding time prolongation and NO inhalation. Lancet. 1993;34:1664-1665
25. Adrie C, Bloch KD, Moreno PR, et al. Inhaled nitric oxide increases coronary artery patency after thrombolysis. Circulation. 1996;94: 1919-1926